Making a case for defining osteonecrosis of the jaw
- PMID: 21317244
- PMCID: PMC3065514
- DOI: 10.1177/0022034510396884
Making a case for defining osteonecrosis of the jaw
Comment on
-
ONJ in two dental practice-based research network regions.J Dent Res. 2011 Apr;90(4):433-8. doi: 10.1177/0022034510387795. Epub 2011 Feb 11. J Dent Res. 2011. PMID: 21317245 Free PMC article.
-
Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRN.J Dent Res. 2011 Apr;90(4):439-44. doi: 10.1177/0022034510397196. Epub 2011 Feb 11. J Dent Res. 2011. PMID: 21317246 Free PMC article.
References
-
- Brown JE, Barrios CH, Diel IJ, Facon T, Fizazi K, Ibrahim T, et al. (2010). Incidence and outcomes of osteonecrosis of the jaw from an integrated analysis of three pivotal randomized double-blind, double-dummy phase 3 trials comparing denosumab and zoledronic acid for treatment of bone metastases in advanced cancer patients or myeloma. Presented at the Cancer and Bone Society 10th International Conference, Sheffield, UK, Sept. 22-25, 2010
-
- Cheung A, Seeman E. (2010). Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. New Engl J Med 363:2473-2474 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
